Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
AOCI Attributable to Parent
Beginning balance (in shares) at Dec. 31, 2021   64,324,628      
Beginning balance at Dec. 31, 2021 $ 112,301 $ 0 $ 294,230 $ (181,898) $ (31)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   826,540      
Issuance of common shares from stock option exercises 979   979    
Issuance of common shares from the employee stock purchase plan (in shares)   165,347      
Issuance of common shares from the employee stock purchase plan 858   858    
Offering costs (271)   (271)    
Vesting of restricted stock units (in shares)   136,777      
Stock-based compensation 13,227   13,227    
Foreign currency translation adjustments, net of tax (97)       (97)
Net unrealized gain (loss) on investments, net of tax 0        
Net loss (40,471)     (40,471)  
Ending balance (in shares) at Sep. 30, 2022   65,453,292      
Ending balance at Sep. 30, 2022 86,526 $ 0 309,023 (222,369) (128)
Beginning balance (in shares) at Jun. 30, 2022   65,010,719      
Beginning balance at Jun. 30, 2022 91,988 $ 0 302,557 (210,551) (18)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   141,216      
Issuance of common shares from stock option exercises 286   286    
Issuance of common shares from the employee stock purchase plan (in shares)   165,347      
Issuance of common shares from the employee stock purchase plan 858   858    
Vesting of restricted stock units (in shares)   136,010      
Stock-based compensation 5,322   5,322    
Foreign currency translation adjustments, net of tax (110)       (110)
Net unrealized gain (loss) on investments, net of tax 0        
Net loss (11,818)     (11,818)  
Ending balance (in shares) at Sep. 30, 2022   65,453,292      
Ending balance at Sep. 30, 2022 $ 86,526 $ 0 309,023 (222,369) (128)
Beginning balance (in shares) at Dec. 31, 2022 65,739,053 65,739,053      
Beginning balance at Dec. 31, 2022 $ 83,219 $ 0 314,884 (231,636) (29)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   1,526,242      
Issuance of common shares from stock option exercises 11,353   11,353    
Issuance of common shares from the employee stock purchase plan (in shares)   292,246      
Issuance of common shares from the employee stock purchase plan $ 1,329   1,329    
Vesting of restricted stock units (in shares)   2,782,008      
Common stock withheld related to net settlement of equity awards (in shares) (998,356) (998,356)      
Common stock withheld related to net settlement of equity awards $ (7,483)   (7,483)    
Stock-based compensation 16,576   16,576    
Foreign currency translation adjustments, net of tax (41)       (41)
Net unrealized gain (loss) on investments, net of tax (35)       (35)
Net loss $ (23,992)     (23,992)  
Ending balance (in shares) at Sep. 30, 2023 69,341,193 69,341,193      
Ending balance at Sep. 30, 2023 $ 80,926 $ 0 336,659 (255,628) (105)
Beginning balance (in shares) at Jun. 30, 2023   67,323,083      
Beginning balance at Jun. 30, 2023 $ 75,392 $ 0 323,844 (248,483) 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 1,176,101 1,176,101      
Issuance of common shares from stock option exercises $ 10,732   10,732    
Issuance of common shares from the employee stock purchase plan (in shares)   157,910      
Issuance of common shares from the employee stock purchase plan $ 707   707    
Vesting of restricted stock units (in shares)   1,148,942      
Common stock withheld related to net settlement of equity awards (in shares) (464,843) (464,843)      
Common stock withheld related to net settlement of equity awards $ (4,811)   (4,811)    
Stock-based compensation 6,187   6,187    
Foreign currency translation adjustments, net of tax (153)       (153)
Net unrealized gain (loss) on investments, net of tax 17       17
Net loss $ (7,145)     (7,145)  
Ending balance (in shares) at Sep. 30, 2023 69,341,193 69,341,193      
Ending balance at Sep. 30, 2023 $ 80,926 $ 0 $ 336,659 $ (255,628) $ (105)